SPMS Patients presented with a mean EDSS about 5.6 ± 1.0 (range 4–6.5) and had received a mean number of 7 ± 3 (range 3–10) NAT infusions. The gene discussed is BRD2; the disease is secondary progressive multiple sclerosis.